Clinical Transplantation

Cover image for Vol. 28 Issue 10

Edited By: Ron Shapiro, MD

Impact Factor: 1.486

ISI Journal Citation Reports © Ranking: 2013: 18/26 (Transplantation); 93/202 (Surgery)

Online ISSN: 1399-0012



Author Guidelines


Clinical Transplantation only accepts online submissions.

The journal to which you are submitting your manuscript employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.

Note to NIH Grantees
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance.  This accepted version will be made publicly available 12 months after publication.  For further information, see http://www.authorservices.wiley.com/bauthor/CTA.asp.

Copyright
The following rules are in agreement with Uniform requirements for manuscripts submitted to biomedical journals accepted by the International Steering Committee (see 1 below). Authors submitting a paper do so on the understanding that the work has not been published before, is not being considered for publication elsewhere, and has been read and approved by all authors. The submission of the manuscript by the authors means that they automatically agree to grant Blackwell Munksgaard the exclusive licence to publish it if and when it is accepted for publication. This licence is a condition of publication and papers will not be passed to the publisher for production unless it has been granted.

Copyright Transfer Agreement
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp

For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

  • Creative Commons Attribution Non-Commercial License OAA
  • Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:

  • Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Open, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see
http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms

Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at:
https://authorservices.wiley.com/bauthor/onlineopen_order.asp

Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

The following rules are in agreement with Uniform requirements for manuscripts submitted to biomedical journals accepted by the International Steering Committee (see 1 below). Authors submitting a paper do so on the understanding that the work has not been published before, is not being considered for publication elsewhere, and has been read and approved by all authors. The submission of the manuscript by the authors means that they automatically agree to grant Wiley-Blackwell the exclusive licence to publish it if and when it is accepted for publication. This licence is a condition of publication and papers will not be passed to the publisher for production unless it has been granted.

GENERAL INFORMATION

Peer Review: All papers will be subject to peer-review.

Rejected manuscripts: will be held for a limited period of time and then destroyed.

Revised manuscripts: must be submitted within 90 days of the date on the decision letter to maintain their original manuscript number. After this time, the manuscript will be treated as a new submission.  Requests in writing for extension to the 90-day time limit will be considered by the Editor-in-Chief.

Institutional Review Board: It is your responsibility, as the author, to have the proper institutional review board (IRB) approve your research study before submitting your manuscript for publication.  Your submission to Clinical Transplantation must state that you have such approval if your paper describes human subjects.

Conflict of Interest: When a manuscript reports on a specific product, the author must enclose a statement disclosing any financial or commercial interest in the manufacturer or distributor of the product, including any corporate funding or affiliations.

Color Charges: Any color illustrations must be paid for by the author. The cost for color figures are $274 USD 1st color image, $90 USD each additional. Authors must complete a Page Charges Agreement form for any manuscript containing color figures and fax it to the production editor at + +65 6643 8599 as soon as the manuscript has been accepted. A copy of this form is included with the eproofing documents sent to authors.

Word Limits: General guidelines for manuscript word limits are listed below.
-Original Articles, no more than 4500 words (all inclusive)
-Review Articles, no more than 6000 words (all inclusive)
-Letter to the Editor, no more than 500 words (all inclusive)

MANUSCRIPT TYPES

Clinical Transplantation accepts Original Articles, Reviews, Opinion/Hypothesis manuscripts and book reviews.

The journal is currently not accepting case reports.

MANUSCRIPT PREPARATION

  • Manuscripts should emphasize clarity and brevity. 
  • All manuscripts are to be submitted in English. Authors are responsible for linguistic and grammatical editing of manuscripts before submission to the Journal.  Manuscripts improperly prepared or edited will be returned to the authors without review by the Editors.
  • Authors should prepare manuscripts in accordance with: “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (N Engl J Med 1997; 336:309-15)
  • Authors: Names department(s) and institution(s) of all authors. Credit for authorship should be based on: [1] substantial contributions to research design, or the acquisition, analysis or interpretation of data; [2] drafting the paper or revising it critically; [3] approval of the submitted and final versions. Authors should meet all three criteria.
  • Corresponding author: Name, address, email address, telephone and fax numbers. (Corresponding author should take responsibility for communicating with all other authors and getting their approval for the final version to be published. During online submission corresponding authors can nominate an individual, who may or may not be an author, to assist them with administration of the publication process.
  • Author contributions: Recommendation: Include a short description of each authors’ contribution immediately before your references. (Examples of categories for authors’ contributions: Concept/design, Data analysis/interpretation, Drafting article, Critical revision of article, Approval of article, Statistics, Funding secured by, Data collection, Other.)
  • Manuscripts should be double spaced with page numbers.
  • Brand names: Drugs, medications, or other material should be listed as generic items. If brand names are used, they should be placed after the generic name in parentheses with the manufacturer's name, city, and state or country.

Abbreviations

Use only standard abbreviations. All units will be metric. Use no roman numerals in the text. In decimals, a decimal point, and not a comma, will be used. Avoid abbreviations in the title. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement. In cases of doubt, the spelling orthodoxy of The Oxford English Dictionary will be adhered to.

Electronic File Formats

Manuscript Text must be saved in Word (.doc) Wordperfect (.wpd) or Rich Text Format (.rtf). Do not submit text in PDF format.

Figures may be submitted in any of the following formats: Word (.doc) Word Perfect (.wpd) Rich Text Format (.rtf) Jpeg (.jpg) GIF (.gif) TIFF(.tif) Powerpoint (.ppt) Excel (.xls) Photoshop (.psd) Bitmap (.bmp) and web pages (.html/.htm)

Manuscript Components and Layout

Relevant components should be arranged in the following order:

Title Page

Should contain (1) a concise informative title; (2) author(s)' names; (3) name of department(s)/institution(s) to which the work is attributed; (4) if the title exceeds 40 characters (letters and spaces), a running head of no more than 40 characters should be provided; (5) name, telephone number, fax number, e-mail and postal address of the author to whom correspondence, proofs, and requests for offprints should be directed.

Abstract

A separate abstract page should contain the following: (1) Authors' surnames and initials. (2) Title of manuscript. (3) Title of Journal, abbreviated as in reference list. (4) The word Abstract followed by a summary of the article. (5) 3-10 key words according to Index Medicus. (6) Name and address of the author to whom requests for offprints should be sent. Abstracts should not exceed 200 words.


Introduction
Present the background briefly, but do not review the subject extensively. Give only pertinent references. State the specific questions you want to answer.

Patients and Methods/Materials and Methods
Describe selection of patients or experimental animals, including controls. Do not use patients' names or hospital numbers. Identify methods, apparatus (manufacturer's name and address), and procedures in sufficient detail to allow other workers to reproduce the results. Provide references and brief descriptions of methods that have been published. When using new methods, evaluate their advantages and limitations. Identify drugs and chemicals, including generic name, dosage, and route(s) of administration.

Indicate whether the procedures were approved by the Ethics Committee of Human Experimentation in your country, or are in accordance with the Helsinki Declaration of 1975.

Results
Present results in logical sequence in tables and illustrations. In the text, explain, emphasize or summarize the most important observations. Units of measurement should be expressed in accordance with Système International d'Unités (SI Units).

Discussion
Do not repeat in detail data given in the Results section. Emphasize the new and important aspects of the study. Relate the observations to other relevant studies. On the basis of your findings (and others'), discuss possible implications/conclusions. When stating a new hypothesis, clearly label it as such.

Tables
Tables should be numbered consecutively with Arabic numerals. Type each table on a separate sheet, with titles making them self-explanatory.

Illustrations

Figures will be either 82, 114 or 173 mm. Lines should be of sufficient thickness to stand reduction (no less than 4 mm wide for a 50% reduction), and letters should be a minimum of 9 pt Arial or an equivalent size. Please make sure that each image does not exceed 3 megabytes.  

Visit http://authorservices.wiley.com/bauthor/illustration.asp for more details. Any color illustrations must be paid for by the author. The cost for color figures are $274 USD 1st color image, $90 USD each additional. Authors must complete a Color Charge Agreement form for any manuscript containing color figures and fax it to the production editor at +1-781-338-8357 as soon as the manuscript has been accepted. A copy of this form is included with the eproofing documents sent to authors (see below).

Abbreviations and Symbols
Use only standard abbreviations. All units will be metric. Use no roman numerals in the text. In decimals, a decimal point, and not a comma, will be used. Avoid abbreviations in the title. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement. In cases of doubt, the spelling orthodoxy of The Oxford English Dictionary will be adhered to.

References
These should be kept to the pertinent minimum and numbered consecutively in the order in which they appear in the text. Identify references in text, tables, and legends by Arabic numerals (in parentheses). Reference cited only in the tables or figure legends should be numbered in accordance with a sequence established by the first identification of that figure or table in the text. Try to avoid using abstracts as references. Include manuscripts accepted, but not published; designate the abbreviated title of the journal followed by (in press). Information from manuscripts not yet accepted should be cited in the text as (submitted). The references must be verified by the author(s) against the original documents. Titles should be abbreviated in accordance with the style used in Index Medicus.

Examples:
International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals.Br Med J 1982: 184: 1766.
Seibel HR, Weymouth RJ, Hume DM, Lee HM, Sterling WA. Ultrastructural examination of homograft human renal biopsies from anastomosis to nephrectomy. Invest Urol 1972: 9: 411.
Seim SK, Maisel KE, Merkel FK. The effect of length of preservation on renal transplant survival. Surg Gynecol Obstet 1977:145: 709.
Sellers AL, Llach F, Franklin S, Gordon A, Fichman M. Renaltransplantation in a community hospital. JAMA 1976: 236: 2866.
Sengar DPS, Opelz G, Terasaki P. Outcome of kidney transplants and suppression of mixed leukocyte culture by plasma. Transplant Proc 1973: 5: 641.
Staquet M, Dalesio O. Designs for phase III trials in cancer. Clinical trials. In eds. Cancer Clinical Trials Methods and Practice. Oxford: Oxford University Press, 1984

SUBMITTING A NEW MANUSCRIPT

ScholarOne Manuscripts

· All manuscripts are submitted through the online system ScholarOne Manuscripts. Hard copy submissions will not be accepted.

· Authors are encouraged to keep electronic and hard copies of all manuscript files. The Journal and Wiley-Blackwell accepts no responsibility for manuscript files that are lost or destroyed through electronic or computer problems.

Getting Started
1. Launch your web browser (Internet Explorer 5 or higher, Netscape 7 or higher, Firefox 1.0.4 or Safari 1.2.4) and go to the Clinical Transplantation ScholarOne Manuscripts homepage (http://mc.manuscriptcentral.com/cltx).

2. Log-in or click the “Create Account” option if you are a first-time user of ScholarOne Manuscripts.

3. If you are creating a new account:

· After clicking on “Create Account”, enter your name and e-mail information and click “Next”. Your e-mail information is very important.

· Enter your institution and address information as appropriate, and then click “Next.”

· Enter a user ID and password of your choice (we recommend using your e-mail address as your user ID), and then select your area of expertise. Click “Finish”.


4. If you have an account but have forgotten your log in details, go to “Password Help” on the Clinical Transplantation ScholarOne Manuscripts homepage and enter your email address. The system will send you an automatic user ID and password reminder.

5. Log-in and select “Author Center.”

Submitting Your Manuscript


1. After you have logged in, click the “Submit a Manuscript” link in the menu bar.

2. Enter data and answer questions as appropriate.

3. Click the “Next” button on each screen to save your work and advance to the next screen.

4. You are required to upload your files.

· Click on the “Browse” button and locate the file on your computer.

· Select the designation of each file in the drop down next to the Browse button.

· When you have selected all files you wish to upload, click the “Upload Files” button.


5. Review your submission (in both PDF and HTML formats) before sending to the Journal. Click the “Submit” button when you are finished reviewing.

You may suspend a submission at any phase before clicking the “Submit” button and save it to submit later. After submission, you will receive a confirmation e-mail. You can also access ScholarOne Manuscripts any time to check the status of your manuscript. The Journal will inform you by e-mail once a decision has been made.

Getting Help With Your Submission
Each page of the ScholarOne Manuscripts website has a ‘Get Help Now’ icon connecting directly to the online support system at http://mcv3support.custhelp.com. Queries can also be e-mailed to support@scholarone.com and telephone support is available 24 hours a day, 5 days a week through the US ScholarOne support office on: +1 434 817 2040, ext 167. If you do not have Internet access or cannot submit online, the Editorial Office will help with online submissions. Please contact Mary Londborg in the Editorial Office, by e-mail (londb001@umn.edu).

SUBMITTING A REVISED MANUSCRIPT

90 day time limit

Revised manuscripts must be received by the Journal for re-review within three months of the original decision date. This applies to both manuscripts returned to the authors for revisions and to manuscripts rejected but invited to submit revisions. If you wish to request an extension, you must inquire before the 90-day time limit.

On-line Submission
If revisions were requested in our decision letter, you will find the manuscript in the author center of the corresponding author under the heading Manuscripts to be Revised

1. Response-to-Reviewers: Click View Comments/Respond to enter comments to the reviewers and to the editors. After entering your responses, click Save Response 

2. Upload revised manuscript: Please submit the revised manuscripts  with all changes highlighted or underlined. This will aid reviewers in seeing where revisions have been made and reduce turnaround times in re-review.

IMPORTANT: UPLOAD ALL YOUR FILES! You must upload all files pertinent to the revised manuscript, including all images, figures and tables. Even if no revisions were made to a particular file, you must upload it again so that it is available to the reviewers in their reviewer center.

ACCEPTED MANUSCRIPTS

Proofs
The corresponding author will receive an email alert containing a link to a web site. A working e-mail address must therefore be provided for the corresponding author. The proof can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following web site:
http://www.adobe.com/products/acrobat/readstep2.html.
This will enable the file to be opened, read on screen and printed out in order for any corrections to be added. Further instructions will be sent with the proof.  if no e-mail address is available. Excessive changes made by the author in the proofs, excluding typesetting errors, will be charged separately.

Queries
Queries from the Production Editor are listed on the last page of the proof. The text to which the queries refer is indicated on the proof by numbers (e.g. Q1) in the margin. Please ensure these are answered in full.  

Corrections
You are responsible for the contents of your paper. We can only publish your paper after we have received your explicit approval of the proofs. Therefore, we would ask you to check the proof carefully, paying particular attention to the accuracy of equations, tables, illustrations (which may have been redrawn), other numerical matter and references (which have been corrected for style but not checked for accuracy, which remains the responsibility of the author). To facilitate PDF proofing, low-resolution images may have been used in this file. However, high-resolution images will be used in the final published version. If you have any queries regarding the quality of the artwork, please contact the Production Editor. As this is a page proof, to which corrections are expensive, please make the fewest possible alterations other than corrections of errors, and wherever a change is essential, please substitute as few words as possible occupying an approximately equal amount of space. If returning the proof by fax, please use a black pen to mark up any corrections. 

Returning Corrections
Please make and keep a copy of the corrected proof for reference in any future correspondence concerning your paper before publication. Please return your corrected proof via fax or email to the CTR proofreader if you have no corrections (email is sufficient) within 3 days of receipt--fax number and email are listed on the proofing instructions. I

Early View
Clinical Transplantation is covered by Wiley-Blackwell's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. They have been fully reviewed, revised and edited for publication, and the authors' final corrections incorporated. Authors cannot make changes to their articles after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows each article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the articles.

Author Services

Online production tracking is now available for your article through Author Services. Author Services enables authors to track their article – once it has been accepted – through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

Offprints
Paper offprints can be ordered using the offprint order information which accompanies the proofs. A free PDF offprint of the paper in its final published form will be sent to the corresponding author's email automatically.

Free access to the final PDF offprint of your article will be available via author services. Please sign up for author services if you would like to access your article PDF offprint upon publication of your paper, and enjoy the many other benefits the service offers. Visit http://authorservices.wiley.com/bauthor/ to sign up for author services.

Author Editing Services
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission or during the review process. Authors wishing to pursue a professional English-language editing service should make contact and arrange payment with the editing service of their choice. For more details regarding the recommended services, please refer to http://authorservices.wiley.- com/bauthor/english_language.asp.

 

SEARCH

SEARCH BY CITATION